{"id":"https://genegraph.clinicalgenome.org/r/59c32363-eab3-4c4e-a163-19e7a92c46c0v1.0","type":"EvidenceStrengthAssertion","dc:description":"**DPM1** was first reported in relation to autosomal recessive Congenital Disorders of Glycosylation by Imbach T, et al., 2000, (PMID: 10642602). At least 9 unique variants (such as missense, frameshift, or deletions) have been reported in humans. Evidence supporting this gene-disease relationship includes both case-level data and experimental data. Variants in this gene have been reported in at least 10 probands from publications (PMIDs:15669674, 10642602, 10642597, 27481510, 16641202, 23856421, 30653653 and 35910228).  Patients have a range of symptoms, including severe developmental delay, microcephaly, seizures, ataxia, peripheral neuropathy, eye abnormalities (retinopathy, nystagmus, strabismus), and severe gastrointestinal involvement. No supporting segregation information is available. The disease mechanism appears to be biallelic loss of function. Heterozygous carriers are reportedly unaffected. This gene-disease relationship is supported by the biochemical function of DPM1, which encodes the cytoplasmic catalytic subunit of dolichol-phosphate-mannose synthase, an enzyme complex that synthesizes dolichol-phosphate-mannose (Dol-P-Man) from GDP-mannose and dolichol-phosphate (PMID: 10835346). DPM1 knockdown in a zebrafish model displayed features of congenital disorder of glycosylation type 1e (CDG1e) associated with DPM1 mutations, such as microcephaly, smaller eyes, kinked tail, and occasional vascular defects in the tail vein. In that same model, rescue of the phenotype was done and was restored. In summary, there is definitive evidence to support this gene-disease relationship. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.  A classification of DEFINITIVE was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on 10/4/23 (SOP Version 9).\n\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/59c32363-eab3-4c4e-a163-19e7a92c46c0","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2a4d2b7f-1de8-4f6c-8136-b62b62e1c226","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2a4d2b7f-1de8-4f6c-8136-b62b62e1c226_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2023-10-10T13:03:24.064Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/2a4d2b7f-1de8-4f6c-8136-b62b62e1c226_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2023-10-04T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a4d2b7f-1de8-4f6c-8136-b62b62e1c226_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a4d2b7f-1de8-4f6c-8136-b62b62e1c226_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64350eb7-6c4f-4d27-8707-56e8bdcb73e4","type":"EvidenceLine","dc:description":"Based on expert call, this was down scored because zebrafish is not the ideal model to capitulate the phenotypes for this disease","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76f02677-649a-4fac-b638-0604cf1cf3c7","type":"Finding","dc:description":"Knocked down DPM1 in zebrafish using morpholino antisense oligonucleotides (MOs). The morpholino animal displayed most features of congenital disorder of glycosylation type 1e (CDG1e) associated with DPM1 mutations, with a smaller head (microcephaly) and smaller eyes, kinked tail, and occasional vascular defects in the tail vein (arrowhead). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26729507","rdfs:label":"DPM1 knockdown in a zebrafish model ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1e45dc97-8f01-4487-90b7-ff81db5b051a","type":"EvidenceLine","dc:description":"the exact extent of the rescue is not detailed in the paper","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47254a70-45e7-4e59-bdb4-0d90bc9076c0","type":"Finding","dc:description":"Injection of human DPM1 mRNA was able to significantly rescue the dpm1 morphant phenotypes showing that the function is conserved between humans and zebrafish and that the phenotypes observed are due to the loss of dpm1 (Supplementary Fig. 15f) ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26729507","rdfs:label":"Rescue of DPM1 knockdown in a zebrafish model","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2a4d2b7f-1de8-4f6c-8136-b62b62e1c226_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de6295ba-5949-4fe1-841e-f2c463f8fb5b","type":"EvidenceLine","dc:description":"upscored because DPM1 function in N-glycosylation pathway is well explained","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db91b7fd-a2d7-415e-ad56-fbca879b8270","type":"Finding","dc:description":"Deficiency of Dol-P-Man synthase, caused by variants in the DPM1 gene, is defined as DPM1-CDG. Patients with mutations in this gene present with intellectual disability, seizures, microcephaly, and dysmorphic features","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10835346","rdfs:label":"Maeda et al. Biochemical evidence of DPM1 ","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/2a4d2b7f-1de8-4f6c-8136-b62b62e1c226_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05eb2e03-51de-479c-9156-8aded13a8d55_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae56e9d5-004b-4d06-81d1-2fe996d68a35","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae56e9d5-004b-4d06-81d1-2fe996d68a35_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transfection of the p.Gly152Val variant plasmid into cultured human 293T cells was performed. Compared to the wild type, the variant was unable to associate with DPM3 based on Western Blot analysis (figure 6).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ae56e9d5-004b-4d06-81d1-2fe996d68a35_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23856421","allele":{"id":"https://genegraph.clinicalgenome.org/r/7417fc96-1fc8-4e4d-ab98-6c57a539afd3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003859.3(DPM1):c.455G>T (p.Gly152Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA150577"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4a42bef1-f146-4989-8c86-8fa3f961b3b7","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a42bef1-f146-4989-8c86-8fa3f961b3b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23856421","allele":{"id":"https://genegraph.clinicalgenome.org/r/1feb8bc0-a03f-421e-8e8d-59c7cc810965","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000020.11:g.(50936263_50940865)_(50948664_50955185)del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/100637"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/05eb2e03-51de-479c-9156-8aded13a8d55","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23856421","rdfs:label":"Male infant","ageType":"AgeAtReport","ageUnit":"Months","ageValue":42,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/1feb8bc0-a03f-421e-8e8d-59c7cc810965"},{"id":"https://genegraph.clinicalgenome.org/r/7417fc96-1fc8-4e4d-ab98-6c57a539afd3"}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0012448","obo:HP_0001263","obo:HP_0005543","obo:HP_0001976","obo:HP_0003236","obo:HP_0002910","obo:HP_0002373","obo:HP_0001250","obo:HP_0003642","obo:HP_0000252","obo:HP_0004855","obo:HP_0012385","obo:HP_0000648","obo:HP_0033106"],"previousTestingDescription":"A karyotype,array CGH, testing for spinal muscular atrophy, and Prader-Willi syndrome were normal.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ae56e9d5-004b-4d06-81d1-2fe996d68a35_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/4a42bef1-f146-4989-8c86-8fa3f961b3b7_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/1bbc927f-f3a1-46ac-8c47-b47088ac493a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89934353-4aa5-47b8-a71d-c082d1097e64","type":"EvidenceLine","dc:description":"consanguineous parents reported ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89934353-4aa5-47b8-a71d-c082d1097e64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16641202","allele":{"id":"https://genegraph.clinicalgenome.org/r/539cf226-e6dd-4232-9b16-ccc8f4196dca","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003859.3(DPM1):c.373-5T>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA150576"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1bbc927f-f3a1-46ac-8c47-b47088ac493a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16641202","rdfs:label":"Patient MS","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/539cf226-e6dd-4232-9b16-ccc8f4196dca"},"detectionMethod":"Reverse transcription polymerase chain reaction (RTâ€“PCR), PCR, and sequencing.","firstTestingMethod":"PCR","phenotypeFreeText":" clumsy and unable to walk without support; stretch reflexes were brisk, and he had a convergent squint","phenotypes":["obo:HP_0001508","obo:HP_0001251","obo:HP_0004855","obo:HP_0001252","obo:HP_0000252","obo:HP_0002373","obo:HP_0006879","obo:HP_0005543","obo:HP_0003642","obo:HP_0100321","obo:HP_0009830","obo:HP_0000488","obo:HP_0001263"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/89934353-4aa5-47b8-a71d-c082d1097e64_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7fde5de2-8326-49ee-960b-672b405e2552_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e785750-d774-441e-982f-42b4c155dedb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e785750-d774-441e-982f-42b4c155dedb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Yes, In Ardiccioni C, et al., 2016 (PMID: 26729507), functional analysis of DPM1 mutants was performed by injecting human DPM1 mRNA following DPM1 morpholino injection, and embryos were scored as normal or affected. S248P, which leads to milder human phenotypes, showed substantial residual activity (Fig. 4g) and (Supplementary Fig. 15g).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0e785750-d774-441e-982f-42b4c155dedb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30653653","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd38b8a1-1963-46de-867a-95b0581b3e55","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003859.3(DPM1):c.742T>C (p.Ser248Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA150575"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1f0dfbd3-676d-45b1-8122-ebe8e7201547","type":"EvidenceLine","dc:description":"There are only 9 exons, the new stop codon will be in the final exon so NMD is not predicted and the variant should be downgraded","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f0dfbd3-676d-45b1-8122-ebe8e7201547_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30653653","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d13b2e2-1df2-40bb-b565-7964aeaa8f68","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003859.3(DPM1):c.564-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA315296461"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.75},{"id":"https://genegraph.clinicalgenome.org/r/7fde5de2-8326-49ee-960b-672b405e2552","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30653653","rdfs:label":"p17","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/fd38b8a1-1963-46de-867a-95b0581b3e55"},{"id":"https://genegraph.clinicalgenome.org/r/1d13b2e2-1df2-40bb-b565-7964aeaa8f68"}],"detectionMethod":"confirmed by conventional Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"paquigiria, Arterial hypertension, ovale foramen, ureterohydronephrosis, pielonephritis, Plaquetopenia","phenotypes":["obo:HP_0001508","obo:HP_0000369","obo:HP_0012444","obo:HP_0001596","obo:HP_0001252","obo:HP_0003642","obo:HP_0003458","obo:HP_0001928","obo:HP_0011123","obo:HP_0032118","obo:HP_0001250","obo:HP_0001433","obo:HP_0011344","obo:HP_0030084","obo:HP_0010553","obo:HP_0000316","obo:HP_0000252"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0e785750-d774-441e-982f-42b4c155dedb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/1f0dfbd3-676d-45b1-8122-ebe8e7201547_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.25},{"id":"https://genegraph.clinicalgenome.org/r/2a4d2b7f-1de8-4f6c-8136-b62b62e1c226_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6aeb1726-b725-4495-8eeb-3297943c8fb0_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16641202","rdfs:label":"Milder Form of CDG Ie in Two French Siblings","family":{"id":"https://genegraph.clinicalgenome.org/r/6aeb1726-b725-4495-8eeb-3297943c8fb0","type":"Family","rdfs:label":"Milder Form of CDG Ie in Two French Siblings","member":{"id":"https://genegraph.clinicalgenome.org/r/1bbc927f-f3a1-46ac-8c47-b47088ac493a"}},"phenotypeFreeText":" clumsy and unable to walk without support; stretch reflexes were brisk, and he had a convergent squint","phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001251","obo:HP_0003642","obo:HP_0009830","obo:HP_0004855","obo:HP_0005543","obo:HP_0100321","obo:HP_0002373","obo:HP_0000488","obo:HP_0001263","obo:HP_0006879","obo:HP_0001252","obo:HP_0000252","obo:HP_0001508"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1bbc927f-f3a1-46ac-8c47-b47088ac493a"}},{"id":"https://genegraph.clinicalgenome.org/r/476a7896-6691-4a2e-9c99-ffd18a1e1917_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10642602","rdfs:label":"2 CDG-Ie patients Sibling","family":{"id":"https://genegraph.clinicalgenome.org/r/476a7896-6691-4a2e-9c99-ffd18a1e1917","type":"Family","rdfs:label":"2 CDG-Ie patients Sibling","member":{"id":"https://genegraph.clinicalgenome.org/r/2bd83793-f45d-499a-994b-f5ad765ed3c3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10642602","rdfs:label":"Sib1 (boy) ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003859.3(DPM1):c.274C>G (p.Arg92Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA118111"}},{"id":"https://genegraph.clinicalgenome.org/r/1da429a5-e7ce-422a-81e6-3e9c00c909ce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003859.3(DPM1):c.628del (p.Gln210ArgfsTer4)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913184718"}}],"detectionMethod":"extraction of RNA from fibroblast cells, followed by reverse transcription and amplification of a specific cDNA","firstTestingMethod":"PCR","phenotypeFreeText":"cant interact socially, the Electroencephalogram was severely abnormal with bilateral epileptiform changes.","phenotypes":["obo:HP_0001250","obo:HP_0006380","obo:HP_0003236","obo:HP_0003642","obo:HP_0000316","obo:HP_0002910","obo:HP_0000252","obo:HP_0200055","obo:HP_0011344","obo:HP_0002705","obo:HP_0001252","obo:HP_0002164","obo:HP_0001433","obo:HP_0003256","obo:HP_0001508"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8a4425b7-1847-433d-8f48-2d2a6b4de231_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10642602","allele":{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/13c3d7a2-c886-4898-b24c-79aefb3ccde9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10642602","allele":{"id":"https://genegraph.clinicalgenome.org/r/1da429a5-e7ce-422a-81e6-3e9c00c909ce"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001433","obo:HP_0002164","obo:HP_0001250","obo:HP_0001508","obo:HP_0003236","obo:HP_0000252","obo:HP_0002910","obo:HP_0006380","obo:HP_0001252","obo:HP_0000316","obo:HP_0003642","obo:HP_0011344","obo:HP_0003256","obo:HP_0200055","obo:HP_0002705"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2bd83793-f45d-499a-994b-f5ad765ed3c3"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9f88a721-180a-466a-a490-ad2d4b4b18e9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b64ae25-9580-4862-b8b9-0ae8e1cfece7","type":"EvidenceLine","dc:description":" The same homozygous variant was scored for pull points in PMID:15669674","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b64ae25-9580-4862-b8b9-0ae8e1cfece7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Ardiccioni C, et al., 2016 (PMID: 26729507), functional analysis of DPM1 mutants was performed by injecting human DPM1 mRNA following DPM1 morpholino injection, and embryos were scored as normal or affected. S248P, which leads to milder human phenotypes, showed substantial residual activity (Fig. 4g) and (Supplementary Fig. 15g). ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7b64ae25-9580-4862-b8b9-0ae8e1cfece7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36579437","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd38b8a1-1963-46de-867a-95b0581b3e55"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9f88a721-180a-466a-a490-ad2d4b4b18e9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36579437","rdfs:label":"P2  ","ageType":"AgeAtOnset","ageUnit":"Days","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd38b8a1-1963-46de-867a-95b0581b3e55"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Cardiac, hepatic & splenic abnormalities","phenotypes":["obo:HP_0000518","obo:HP_0000707","obo:HP_0001252","obo:HP_0000510","obo:HP_0001263"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7b64ae25-9580-4862-b8b9-0ae8e1cfece7_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5d232613-9e70-4a50-86f9-b023f6cf7ad2_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94f55604-dffc-4a72-b6ed-ae18c090d06a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94f55604-dffc-4a72-b6ed-ae18c090d06a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35279850","allele":{"id":"https://genegraph.clinicalgenome.org/r/df5edafd-5ab4-46f4-9282-0407eff10633","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003859.3(DPM1):c.1A>C (p.Met1Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9909287"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b2c0da47-9688-4487-846e-b72eb5a65485","type":"EvidenceLine","calculatedScore":0.1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2c0da47-9688-4487-846e-b72eb5a65485_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35279850","allele":{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5d232613-9e70-4a50-86f9-b023f6cf7ad2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35279850","rdfs:label":"P89_CDGIx","allele":[{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589"},{"id":"https://genegraph.clinicalgenome.org/r/df5edafd-5ab4-46f4-9282-0407eff10633"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"No ataxia (but no independent sitting or walking)","phenotypes":["obo:HP_0000369","obo:HP_0001250","obo:HP_0000609","obo:HP_0002020","obo:HP_0004404","obo:HP_0000316","obo:HP_0005556","obo:HP_0002126","obo:HP_0001252","obo:HP_0000707","obo:HP_0000252","obo:HP_0011344","obo:HP_0002205","obo:HP_0000649","obo:HP_0001773","obo:HP_0004279"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b2c0da47-9688-4487-846e-b72eb5a65485_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/94f55604-dffc-4a72-b6ed-ae18c090d06a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/fe77b05b-df3f-4a0a-b927-03eda7f470dd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b57193b2-2bd1-4f6e-bea2-3e210a75eae7","type":"EvidenceLine","dc:description":"Based on expert panel discussion for RFT1 curation, up-scoring because of genotype testing and specific type 1 transferrin isoform profile","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b57193b2-2bd1-4f6e-bea2-3e210a75eae7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35910228","allele":{"id":"https://genegraph.clinicalgenome.org/r/df5edafd-5ab4-46f4-9282-0407eff10633"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/bbe63b61-464f-4217-967e-60020d515ceb","type":"EvidenceLine","dc:description":"Based on expert panel discussion for RFT1 curation, up-scoring because of genotype testing and specific type 1 transferrin isoform profile","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bbe63b61-464f-4217-967e-60020d515ceb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35910228","allele":{"id":"https://genegraph.clinicalgenome.org/r/be723b2c-fcbc-43e7-9a4a-94a9a08f0346","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003859.3(DPM1):c.239_241del (p.Lys80del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA635765982"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/fe77b05b-df3f-4a0a-b927-03eda7f470dd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35910228","rdfs:label":"Female Patient ","ageType":"AgeAtDiagnosis","ageUnit":"Weeks","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/df5edafd-5ab4-46f4-9282-0407eff10633"},{"id":"https://genegraph.clinicalgenome.org/r/be723b2c-fcbc-43e7-9a4a-94a9a08f0346"}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypeFreeText":"non-febrile seizures from the age of 3 weeks, characterized by short myoclonic episodes mainly of the limbs\n\nEEG revealed a burst-suppression pattern with discontinuous background activity, missing sleep-wake cycle and in addition detected multiple short seizures\n\nincapability of drinking, muted crying and diminished or absent reflexes","phenotypes":["obo:HP_0001976","obo:HP_0008905","obo:HP_0001252","obo:HP_0003642","obo:HP_0001263","obo:HP_0004719","obo:HP_0001302","obo:HP_0001903","obo:HP_0000316","obo:HP_0000278","obo:HP_0002705","obo:HP_0030084","obo:HP_0005280","obo:HP_0010851","obo:HP_0002104"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b57193b2-2bd1-4f6e-bea2-3e210a75eae7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/bbe63b61-464f-4217-967e-60020d515ceb_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4774d8f8-af20-4436-b68c-60992cc03eed_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf94fba8-f43e-4f79-b526-d075e1949f45","type":"EvidenceLine","dc:description":"European (non-Finnish) : 6/129164 (0.00004645)","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf94fba8-f43e-4f79-b526-d075e1949f45_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"A patient from PMID:10642602 had the same mutation that was transfected into DolP-Man synthase-deficient mouse BW5147 Thy1-E cells resulting in partial restoration of Thy1 expression.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cf94fba8-f43e-4f79-b526-d075e1949f45_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10642597","allele":{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/4774d8f8-af20-4436-b68c-60992cc03eed","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10642597","rdfs:label":"Patient CH ","ageType":"AgeAtReport","ageUnit":"Months","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589"},"detectionMethod":"reverse transcription-polymerase chain reaction (RT-PCR)","firstTestingMethod":"PCR","phenotypeFreeText":"Neonatal apnoeic spells","phenotypes":["obo:HP_0001252","obo:HP_0025404","obo:HP_0100704","obo:HP_0001250","obo:HP_0003642","obo:HP_0012448","obo:HP_0001976","obo:HP_0011344","obo:HP_0003236"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cf94fba8-f43e-4f79-b526-d075e1949f45_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/2bd83793-f45d-499a-994b-f5ad765ed3c3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a4425b7-1847-433d-8f48-2d2a6b4de231","type":"EvidenceLine","dc:description":"European (non-Finnish):  6/129164 (0.00004645) ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a4425b7-1847-433d-8f48-2d2a6b4de231_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Vector with mutation was transfected into DolP-Man synthase-deficient mouse BW5147 Thy1-E cells. The 274C>G mutation partially restored Thy1 expression. (Figure 6).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8a4425b7-1847-433d-8f48-2d2a6b4de231_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/13c3d7a2-c886-4898-b24c-79aefb3ccde9","type":"EvidenceLine","dc:description":"A protein product with deletion of the 24 COOH-terminal amino acids was made but the functional assay showed no activity for this specific variant.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13c3d7a2-c886-4898-b24c-79aefb3ccde9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Vector with mutation was transfected into DolP-Man synthase-deficient mouse BW5147 Thy1-E cells. The 628delC deletion failed to restore Thy1 expression, indicating complete abolition of DolP-Man synthase activity (Figure 6)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/13c3d7a2-c886-4898-b24c-79aefb3ccde9_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2bd83793-f45d-499a-994b-f5ad765ed3c3"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/bc9bba40-5944-4154-b901-ba8823c8b0ec_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a3133c0-a2c7-4e20-9cdf-c2276ee34896","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a3133c0-a2c7-4e20-9cdf-c2276ee34896_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Ardiccioni C, et al., 2016 (PMID: 26729507), functional analysis of DPM1 mutants was performed by injecting human DPM1 mRNA following DPM1 morpholino injection, and embryos were scored as normal or affected. S248P, which leads to milder human phenotypes, showed substantial residual activity (Fig. 4g) and (Supplementary Fig. 15g). \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4a3133c0-a2c7-4e20-9cdf-c2276ee34896_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15669674","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd38b8a1-1963-46de-867a-95b0581b3e55"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/bc9bba40-5944-4154-b901-ba8823c8b0ec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15669674","rdfs:label":"9-year-old girl ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/fd38b8a1-1963-46de-867a-95b0581b3e55"},"detectionMethod":"\"The nine exons of the DPM1 gene and the four exons of DPM2 were screened by D-HPLC. Abnormal fragments were further analyzed by direct sequencing.\"\n","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"dysmorphia, endotropia, Thick metopic suture, Transitory hypodensities in basal ganglia\n\nShe had increased levels of creatine kinase (436^303 U/L, normal 20^130) and low levels of antithrombin III, protein C, protein S and (34%, 55%, 44% and 40% respectively)","phenotypes":["obo:HP_0003236","obo:HP_0012448","obo:HP_0001252","obo:HP_0032323","obo:HP_0002625","obo:HP_0000252","obo:HP_0003642","obo:HP_0001929","obo:HP_0011968","obo:HP_0011344","obo:HP_0004855","obo:HP_0001250","obo:HP_0001976","obo:HP_0011107","obo:HP_0000648","obo:HP_0000243","obo:HP_0100739","obo:HP_0001513","obo:HP_0000639","obo:HP_0011220","obo:HP_0005543"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4a3133c0-a2c7-4e20-9cdf-c2276ee34896_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/535698d2-4813-46aa-b1da-11a283c4bf4f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7db42518-0e63-4baf-9a42-e171f4880881","type":"EvidenceLine","dc:description":"Based on expert panel discussion for RFT1 curation, up-scoring because of genotype testing and specific type 1 transferrin isoform profile\n\nEuropean (non-Finnish): 8/113680 (0.00007037)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7db42518-0e63-4baf-9a42-e171f4880881_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27481510","allele":{"id":"https://genegraph.clinicalgenome.org/r/df5edafd-5ab4-46f4-9282-0407eff10633"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/93bc6730-6936-4839-9f95-8cae7a29ba01","type":"EvidenceLine","dc:description":"Based on expert panel discussion for RFT1 curation, up-scoring because of genotype testing and specific type 1 transferrin isoform profile\n\nEuropean (non-Finnish) : 6/129164 (0.00004645)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93bc6730-6936-4839-9f95-8cae7a29ba01_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"A patient from PMID:10642602 had the same mutation that was transfected into DolP-Man synthase-deficient mouse BW5147 Thy1-E cells resulting in partial restoration of Thy1 expression.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/93bc6730-6936-4839-9f95-8cae7a29ba01_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27481510","allele":{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.75},{"id":"https://genegraph.clinicalgenome.org/r/535698d2-4813-46aa-b1da-11a283c4bf4f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27481510","rdfs:label":"10 yr old girl ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589"},{"id":"https://genegraph.clinicalgenome.org/r/df5edafd-5ab4-46f4-9282-0407eff10633"}],"detectionMethod":"mutations were confirmed in the proband and the parents via sanger sequencing ","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Long great toes, wide sandal gap, food protein induced enterocolitis syndrome (FPIES)","phenotypes":["obo:HP_0000316","obo:HP_0001263","obo:HP_0005280","obo:HP_0003236","obo:HP_0001250","obo:HP_0000252","obo:HP_0003642","obo:HP_0000494","obo:HP_0001257","obo:HP_0000319","obo:HP_0002057","obo:HP_0001371","obo:HP_0010806","obo:HP_0001252"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/93bc6730-6936-4839-9f95-8cae7a29ba01_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/7db42518-0e63-4baf-9a42-e171f4880881_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/72d8da94-d5c6-460b-8208-ae606af6aed2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a05693d5-40e0-4eab-9338-d2a36f2a9068","type":"EvidenceLine","dc:description":"European (non-Finnish): 6/129164 (0.00004645)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a05693d5-40e0-4eab-9338-d2a36f2a9068_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"A patient from PMID:10642602 had the same mutation that was transfected into DolP-Man synthase-deficient mouse BW5147 Thy1-E cells resulting in partial restoration of Thy1 expression.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a05693d5-40e0-4eab-9338-d2a36f2a9068_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10642597","allele":{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1827862e-326c-4197-8ace-269df39acaf2","type":"EvidenceLine","dc:description":"Figure 5 shows RT-PCR products\nEuropean (non-Finnish ): 2/113618 (0.00001760)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1827862e-326c-4197-8ace-269df39acaf2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10642597","allele":{"id":"https://genegraph.clinicalgenome.org/r/9807fa64-a73e-481b-bf28-dc12dd11d1ea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003859.3(DPM1):c.331_343del (p.Gly111LeufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA510893874"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/72d8da94-d5c6-460b-8208-ae606af6aed2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10642597","rdfs:label":"Patient PY ","ageType":"AgeAtReport","ageUnit":"Months","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/9807fa64-a73e-481b-bf28-dc12dd11d1ea"},{"id":"https://genegraph.clinicalgenome.org/r/63fc088f-6ff6-4c26-bfda-3219d432d589"}],"detectionMethod":"reverse transcription-polymerase chain reaction (RT-PCR)","firstTestingMethod":"PCR","phenotypeFreeText":"Neonatal apnoeic spells, Frontal lobe hypoplasia and Cerebellar atrophy","phenotypes":["obo:HP_0011344","obo:HP_0000486","obo:HP_0003642","obo:HP_0003236","obo:HP_0004855","obo:HP_0001987","obo:HP_0012448","obo:HP_0001976","obo:HP_0001252","obo:HP_0025404","obo:HP_0001508","obo:HP_0001271","obo:HP_0001250","obo:HP_0001789","obo:HP_0011968","obo:HP_0100704","obo:HP_0002910","obo:HP_0001643","obo:HP_0005543"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1827862e-326c-4197-8ace-269df39acaf2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a05693d5-40e0-4eab-9338-d2a36f2a9068_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":7041,"specifiedBy":"GeneValidityCriteria9","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/tWNQXkhQWEQ","type":"GeneValidityProposition","disease":"obo:MONDO_0012123","gene":"hgnc:3005","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2a4d2b7f-1de8-4f6c-8136-b62b62e1c226-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}